Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.

from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/R9LI0Tn
https://ift.tt/oYV6vUh